首页|活血化瘀生肌方对瘀血阻络型胃食管反流病肠道菌群、胃蛋白酶原、食管动力及胃黏膜损伤的影响

活血化瘀生肌方对瘀血阻络型胃食管反流病肠道菌群、胃蛋白酶原、食管动力及胃黏膜损伤的影响

扫码查看
目的 观察活血化瘀生肌方对瘀血阻络型胃食管反流病患者肠道菌群、胃蛋白酶原、食管动力及胃黏膜损伤的影响.方法 将115 例胃食管反流病患者按照随机数字表法分为2 组,对照组57 例予常规西医治疗,治疗组 58例在对照组治疗基础上予活血化瘀生肌方治疗.连续治疗1 个月.比较2 组治疗前后血清胃蛋白酶原Ⅰ(PGⅠ)、转化生长因子α(TGF-α)、胃蛋白酶原Ⅱ(PGⅡ)、胆囊收缩素(CCK)水平,肠道葡萄球菌、乳酸菌、双歧杆菌数量,食管动力指标(食管括约肌压力、食管远端收缩积分平均值、总反流时间百分比),中医证候评分,胃酸分泌量,胃液胆酸量,以及反流性疾病问卷(RDQ)评分,统计2 组临床疗效.结果 治疗组总有效率 96.55%(56/58),对照组总有效率 82.46%(47/57),治疗组临床疗效优于对照组(P<0.05).2 组治疗后PGⅠ、TGF-α水平均较本组治疗前升高(P<0.05),且治疗组治疗后均高于对照组(P<0.05);2 组治疗后PGⅡ、CCK水平均降低(P<0.05),治疗组治疗后均低于对照组(P<0.05).2 组治疗后肠道乳酸菌、双歧杆菌数量均较本组治疗前升高(P<0.05),治疗组治疗后均高于对照组(P<0.05);2 组治疗后葡萄球菌数量均降低(P<0.05),且治疗组治疗后低于对照组(P<0.05).2 组治疗后食管括约肌压力、食管远端收缩积分平均值均较本组治疗前升高(P<0.05),且治疗组治疗后均高于对照组(P<0.05);2 组治疗后总反流时间百分比均较本组治疗前降低(P<0.05),且治疗组治疗后低于对照组(P<0.05).2 组治疗后中医证候各项评分均较本组治疗前降低(P<0.05),且治疗组治疗后均低于对照组(P<0.05).2 组治疗后胃酸分泌量、胃液胆酸量及RDQ评分均较本组治疗前降低(P<0.05),且治疗组治疗后均低于对照组(P<0.05).结论 活血化瘀生肌方治疗瘀血阻络型胃食管反流病患者,可改善胃蛋白酶原指标,促进胃黏膜损伤修复,平衡肠道菌群,提高食管动力,缓解患者中医证候及临床症状,提升临床疗效.
Effects of Huoxue Huayu Shengji Formula on intestinal flora,pepsinogen,esophageal motility,gastric mucosal injury repair in patients with gastroesophageal reflux diseaseof blood stasis type
Objective To observe the effects of Huoxue Huayu Shengji Formula on intestinal flora,pepsinogen,esopha-geal motility,gastric mucosal injury repair in patients with gastroesophageal reflux disease(GERD)of blood stasis type.Meth-ods A total of 115 GERD patients were randomly assigned in a1∶1 ratio to routine Western medicine(RWM,control group)or Huoxue Huayu Shengji Formula+RWM(treatment group)for 1 month.The aim was to compare serum pepsinogen I(PGI),transforming growth factor alpha(TGF-α),pepsinogen Ⅱ(PGⅡ),cholecystokinin(CCK),amount of Staphylococcus,Lac-tobacillus and Bifidobacterium,esophageal motility indexes(esophageal sphincter pressure,mean distal contractile integral[DCI],percentage total reflux time),traditional Chinese medi-cine(TCM)syndrome score,gastric acid output,gastric bile acid content,Reflux Disease Questionnaire(RDQ).The curative effect was assessed.Results The overall effective rate in the treatment group was better than that in the control group(96.55%[56/58]vs 82.46%[47/57],P<0.05).After treatment,significantly increased PGⅠand TGF-α levels,and decreased PGⅡ and CCK levels were found in the both groups than those before treatment(all P<0.05),and the different was significant between groups for the above indexes(all P<0.05).Signifi-cantly increased amount of Lactobacillus and Bifidobacterium,and decreased amount of Staphylococcus were detected in the both groups(all P<0.05),and the treatment group was superior to the control group for amount of Staphylococcus,Lactobacillus and Bifidobacterium(all P<0.05).Significantly higher esophageal sphincter pressure and mean DCI,and reducedproportion of total reflux timewere found in the both groups after treatment(all P<0.05),which were significantly pronounced in treatment group(all P<0.05).After treatment,TCM symptom scores in the both groups were significantly decreased(P<0.05),which de-creased notably in the treatment group compared with the control group(P<0.05).After treatment,gastric acid output,gastric bile acid content,RDQ score in the both groups were significantly decreased(P<0.05),which were significantly lower in the treatment group than in the control group(P<0.05).Conclusion Huoxue Huayu Shengji Formula can improve pepsinogen in-dicators,promote gastric mucosal injury repair,balance intestinal flora,improve esophageal motility,TCM syndromes and clini-cal symptoms,and enhance clinical efficacy in patients with GERD of blood stasis type.

Gastroesophageal reflux diseaseTraditional Chinese medicine therapyPepsinogenGastric mucosaIn-testinal floraEsophageal motility

金莹、吴胜炜、郭法杰、徐胜利

展开 >

安徽省宿州市中医医院中药房,安徽 宿州 234000

安徽省宿州市中医医院老年科,安徽 宿州 234000

安徽省宿州市中医医院脾胃病科,安徽 宿州 234000

胃食管反流病 中药疗法 胃蛋白酶原 胃黏膜 肠道菌群 食管动力

2021年度中国民族医药学会科研项目

2021Z1126-1002009

2024

河北中医
河北省医学情报研究所,河北省中医药学会

河北中医

CSTPCD
影响因子:0.951
ISSN:1002-2619
年,卷(期):2024.46(8)
  • 17